RPRD1B and breast carcinoma: Luciferase reporter assays showed that restoring miR-138 expression reduced CREPT expression levels, while upon CREPT 3′-UTR mutation, the interaction between both was disrupted, confirming the specificity of the miR-138’s/CREPT axis in breast cancer cell progression [11].